Monash-led PADDI trial wins award

ACTA clinical trials 2022 awards were made on 20 May 2022,
International Clinical Trials Day. Professors Andrew Forbes (left)
and Tomas Corcoran (right) accepted the award for 'Excellence in
Trial Statistics' on behalf of the PADDI trial investigators.

The Perioperative Administration of Dexamethasone and Infection (PADDI) trial has been honoured by the 2022 Australian Clinical Trials Alliance (ACTA) Excellence in Trial Statistics Award.

The award was presented on International Clinical Trials Day, which is held on 20 May each year to recognise the outstanding contribution of the sector in developing and leading investigator-led clinical trials.

Dexamethasone treatment safe in surgery

Profs Tomas Corcoran, Allen Cheng, Paul Myles,
A/Prof Trish Peel and Ms Karen Goulding explain the

research which has shown that dexamethasone is safe in
surgery. See NEJM study & webinar video 

The steroid drug, dexamethasone, is often given by anaesthetists during surgery.  However, because of its effects on the immune system there has been growing concern that it may increase the risk of wound infections, particularly in vulnerable populations such as patients with diabetes.

PADDI Trial results webinar: 6 May, 7-8 am

The Australian and New Zealand College of Anaesthetists Clinical Trials Network (ANZCA CTN) and Monash University are delighted to invite you to a virtual public webinar announcing the results of the Perioperative Administration of Dexamethasone and Infection (PADDI) trial. The webinar will be held on Thursday 6 May, 2021 at 7-8am AEST. (Note, flyer with international times here). More information and register here.